Carnitne Palmitoyltranferase Type 1 Defciency: A Case Report of Faty Acid Oxidaton Disorder Encephalopathy
Background: Carnitine palmitoyltransferase-1 (CPT-1) deficiency is a rare autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation with fewer than 30 case reports.
Case report: A 30-month-old child with fever and loss of consciousness was referred to our hospital. She had symptoms of colds for three days that were treated, but she had anorexia. Her abdomen was soft and hepatomegaly 5 cm below the edge of the rib was detected. According to a neurological consultation, with the probability of a seizure, the patient began to receive levetiracetam. The patient was treated with sodium benzoate due to her decreased level of consciousness and increased blood ammonia (300). In the acylcarnitine profile, mildly elevated levels of single acylcarnitine were seen to confirm the diagnosis of CPT-1 deficiency.
Conclusions: CPT-1 deficiency is a rare autosomal recessive defect of mitochondrial long- chain fatty acid oxidation that presents as an acute “Reye-like” hepatic encephalopathy and non-ketotic hypoglycemia, developmental delay, and hepatomegaly.
 Rinaldo P, Coates PM, Vockley J. In Memoriam. Molecular Genetcs and Metabolism. 2005; 86(3):335-6. [DOI:10.1016/j. ymgme.2005.09.003]
 Naher N, Nahar LN, Sultana S, Matn A, Fakir MHJ, Islam MR. Carnitne palmitoyl tranferase type 1 defciency in faty acid oxidaton disorder: A case report. Journal of Shaheed Suhrawardy Medical College. 2014; 6(1):38-40. [DOI:10.3329/jssmc.v6i1.31491]
 Sindgikar SP, et al., Faty Acid oxidaton disorder with secondary mitochondrial energy producton defect: A case report. Indian Jour nal of Clinical Biochemistry: IJCB. 2014; 29(4):514-6. [DOI:10.1007/ s12291-013-0391-3] [PMID] [PMCID]
 Rinaldo P, Matern D, Bennet MJ. Faty acid oxidaton disorders. Annual Review of Physiology. 2002; 64:477-502. [DOI:10.1146/annurev.physiol.64.082201.154705] [PMID]
 Brown NF, Mullur RS, Subramanian I, Esser V, Bennet MJ, Saudubray JM, et al. Molecular characterizaton of L-CPT I defciency in six patents: Insights into functon of the natve enzyme. Journal of Lipid Research. 2001; 42(7):1134-42. [PMID]
 Bennet, M., S. Narayan, and A. Santani, Carnitne palmitoyltransferase 1A defciency. GeneReviews. In: GeneReviews [Internet]. Seatle (WA): University of Washington; 1993-2020. [PMID]
 Fingerhut R, Röschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, et al. Hepatc carnitne palmitoyltransferase I defciency: Acylcarnitne profles in blood spots are highly specifc. Clinical Chemistry. 2001; 47(10):1763-8. [DOI:10.1093/clinchem/47.10.1763] [PMID]
 Sim KG, Wiley V, Carpenter K, Wilcken B. Carnitne palmitoyltransferase I defciency in neonate identfed by dried blood spot free carnitne and acylcarnitne profle. Journal of Inherited Metabolic Disease. 2001; 24(1):51-9. [DOI:10.1023/A:1005606805951] [PMID]
 Price N, van der Leij F, Jackson V, Corstorphine C, Thomson R, Sorensen A, et al. A novel brain-expressed protein related to carnitne palmitoyltransferase I. Genomics. 2002; 80(4):433-42. [DOI:10.1006/geno.2002.6845] [PMID]
 Roe CR, Ding J. Mitochondrial faty acid oxidaton disorders. In: David L. Valle, Stylianos Antonarakis, Andrea Ballabio, Arthur L. Beaudet, Grant A. Mitchell, editors. The Online Metabolic and Molecular Bases of Inherited Disease. Pennsylvania: McGraw-Hill Medical; 2001; 2297-326. [DOI:10.1036/ommbid.129]
|Issue||Vol 5 No 4 (2020): Autumn|
|Faty acid Oxidaton Encephalopathy|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|